Monitoring Neoadjuvant Chemotherapy Response in Breast Cancer Patients Using Diffuse Optical Spectroscopic Imaging

NCT02510456 · clinicaltrials.gov ↗

COMPLETED

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DEVICE: Diffuse Optical Spectroscopy Imaging (DOSI) - Neoadjuvant Chemo (NAC) Cohort
DEVICE: Diffuse Optical Spectroscopy Imaging (DOSI) - Non-NAC Cohort

Sponsor

Boston Medical Center

Collaborators

[object Object]